Pharmacogenomics Offers New Opportunities in the Molecular Diagnostics Field

Molecular diagnostics is making it possible to detect cancer and infectious disease more accurately at an earlier stage than before. The report covers key issues facing molecular diagnostics makers and their component suppliers.

Rockville, MD, August 27, 2010 --( has announced the addition of Business Insights’s new report “The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine” to their collection of Molecular Diagnostics market reports. For more information, visit

Molecular diagnostics, essentially the analysis of DNA and RNA at the molecular level, is a fast-growing business, made possible by the growing understanding of the human genome, which has spurred growth in the diagnostic business. Given the established importance of DNA in molecular biology and its central role in determining the fundamental operation of cellular processes, molecular diagnostics is making it possible to detect infectious disease and cancer more accurately at an earlier stage than before. The technology also is optimizing testing for sexually transmitted diseases and genetic testing. Molecular diagnostics is also addressing the need for tests that monitor the therapeutic efficacy of pharmaceuticals. In this way, it has evolved into an important business opportunity for in-vitro diagnostics makers.

Molecular diagnostics is expanding beyond just the identification of infections. It is becoming an integral part of disease management and therapy, finding such applications as patient stratification, drug regimen selection, toxicity avoidance, therapeutic monitoring, and detection of predisposition to disease. Hospitals and diagnostic laboratories using molecular diagnostic techniques need products that guarantee the highest levels of reliability and the greatest speed. Reliability is essential, because an inaccurate or missed diagnosis can be a matter of life and death. Another issue driving the need for new molecular diagnostics involves the ability of microorganisms to evade and even inactivate potent antibiotics, causing health care givers to be faced with substantial infectious disease challenges. The variety of technologies used in molecular diagnostics has transformed clinical laboratory medicine.

Key features of this report

Explanation of how molecular diagnostics represents a business opportunity for the IVD industry. What is causing this growth - increasing diagnostic efficiency, optimizing treatment with drugs?
Evaluation of the drivers and trends behind the growth of molecular diagnostics…how the science and technology of molecular diagnostics is becoming more important to clinical labs and drug companies with its increasing sensitivity and new platform technologies.
Key challenges facing molecular diagnostic manufacturers and those companies looking to enter the market: The need for developing simple to use, automated products; dealing with a complex regulator environment; gaining access to financing and innovation.
Analysis of markets by key types of testing, products, and by country; analysis showing the top products and opportunities.

For more information, visit

Veronica Franco

Veronica Franco